Make your selection

List of Metformin and group Mental Disorder intersectionsRows: 51■ Human ■ Animal ■ Risk ■ Review

SubstanceConditionSeqSrc
PMID
Dtl
Title
Metformin Age-Related Cognitive Decline
2
PM
36224264📋Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway
Metformin Age-Related Cognitive Decline
1
PM
35843348📋Metformin use and brain atrophy in nondemented elderly individuals with diabetes
Metformin Alzheimer's Disease
14
PM
38842663📋Beneficial effect of lupeol and metformin in mouse model of intracerebroventricular streptozotocin induced dementia
Metformin Alzheimer's Disease
13
PM
38582410📋The role of the cholinergic system in the memory-protecting effects of metformin in a model of scopolamine-induced memory impairment in aged rats
Metformin Alzheimer's Disease
12
PM
38333746📋Metformin improves memory via AMPK/mTOR-dependent route in a rat model of Alzheimer's disease
Metformin Alzheimer's Disease
11
PM
37985011📋Alzheimer's disease-related brain insulin resistance and the prospective therapeutic impact of metformin
Metformin Alzheimer's Disease
10
PM
37780174📋Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation
Metformin Alzheimer's Disease
9
PM
37483818📋Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease
Metformin Alzheimer's Disease
7
PM
36723832📋Metformin mitigates amyloid β1-40-induced cognitive decline via attenuation of oxidative/nitrosative stress and neuroinflammation
Metformin Alzheimer's Disease
6
PM
36464874📋Effects of metformin on modulating the expression of brain-related genes of APP/PS1 transgenic mice based on Single Cell Sequencing
Metformin Alzheimer's Disease
5
PM
36422837📋Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
Metformin Alzheimer's Disease
4
PM
35902387📋Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study
Metformin Alzheimer's Disease
3
PM
35802659📋Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin
Metformin Alzheimer's Disease
2
PM
35395244📋Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease
Metformin Alzheimer's Disease
1
PM
34657937📋Metformin and cyanidin 3- O-galactoside from Aronia melanocarpa synergistically alleviate cognitive impairment in SAMP8 mice
Metformin Alzheimer's Disease
8
PM
29253574📋Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice
Metformin Anxiety
3
PM
38284725📋The Antidiabetic Drug Metformin Attenuated Depressive and Anxietylike Behaviors and Oxidative Stress in the Brain in a Rodent Model of Inflammation Induced by Lipopolysaccharide in Male Rats
Metformin Anxiety
2
PM
37798418📋Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons
Metformin Anxiety
1
PM
27581932📋Sirtuin 1 and 7 Mediate Resveratrol-Induced Recovery From Hyper-Anxiety in High-Fructose-Fed Prediabetic Rats
Metformin Autism Spectrum Disorder
1
PM
37133558📋The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy
Metformin Cognitive Disorders
4
PM
37483818📋Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease
Metformin Cognitive Disorders
3
PM
37085892📋Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study
Metformin Cognitive Disorders
2
PM
36404813📋Metformin inhibits cardiometabolic syndrome associated cognitive deficits in high fat diet rats
Metformin Cognitive Disorders
1
PM
34547248📋Evaluation of nootropic activity of telmisartan and metformin on diazepam-induced cognitive dysfunction in mice through AMPK pathway and amelioration of hippocampal morphological alterations
Metformin Delirium
1
PM
36399107📋The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study
Metformin Dementia
9
PM
37878862📋Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction
Metformin Dementia
8
PM
37878309📋Metformin Cessation and Dementia Incidence
Metformin Dementia
7
PM
37869901📋Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta-analysis
Metformin Dementia
6
PM
37830443📋Heterogeneous treatment effects of metformin on risk of dementia in patients with type 2 diabetes: A longitudinal observational study
Metformin Dementia
5
PM
37395154📋Dementia risk in patients with type 2 diabetes: Comparing metformin with no pharmacological treatment
Metformin Dementia
4
PM
36657564📋Metformin adherence reduces the risk of dementia in patients with diabetes: A population-based cohort study
Metformin Dementia
3
PM
36496454📋Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia
Metformin Dementia
2
PM
36220195📋Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes
Metformin Dementia
1
PM
35847477📋Metformin and the risk of dementia based on an analysis of 396,332 participants
Metformin Depression
8
PM
38286229📋Possible role of metformin as an antidepressant in diabetes
Metformin Depression
7
PM
38284725📋The Antidiabetic Drug Metformin Attenuated Depressive and Anxietylike Behaviors and Oxidative Stress in the Brain in a Rodent Model of Inflammation Induced by Lipopolysaccharide in Male Rats
Metformin Depression
6
PM
36347837📋Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers?
Metformin Depression
5
PM
36185927📋Metformin for the Improvement of Comorbid Depression Symptoms in Diabetic Patients: A Systematic Review
Metformin Depression
4
PM
36108876📋Association of metformin and depression in patients with type 2 diabetes
Metformin Depression
3
PM
35931897📋Metformin improves depressive-like behavior in experimental Parkinson's disease by inducing autophagy in the substantia nigra and hippocampus
Metformin Depression
2
PM
35338947📋Diabetes, antidiabetic medications and risk of depression - A population-based cohort and nested case-control study
Metformin Depression
1
PM
28827076📋Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats
Metformin Diabetic Encephalopathy
3
PM
36751729📋The effects of endurance exercise and metformin on memory impairment caused by diabetes
Metformin Diabetic Encephalopathy
2
PM
36090264📋Metformin use is associated with a reduced risk of cognitive impairment in adults with diabetes mellitus: A systematic review and meta-analysis
Metformin Diabetic Encephalopathy
1
PM
31188777📋Trigonella Foenum-Graceum Seed (Fenugreek) Hydroalcoholic Extract Improved the Oxidative Stress Status in a Rat Model of Diabetes-Induced Memory Impairment
Metformin Huntington's Disease
1
PM
35367225📋Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder
Metformin Mood Disorders
1
PM
36170869📋Metformin is Protective Against the Development of Mood Disorders
Metformin Psychiatric Disorders
1
PM
36191545📋The role of metformin as a treatment for neuropsychiatric illness
Metformin Rett Syndrome
1
PM
36442649📋Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome
Metformin Schizophrenia
2
PM
37821461📋Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex
Metformin Schizophrenia
1
PM
37502816📋The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression